Accepted by Scopus and Clarivate Analytics to be indexed in Science Citation Index Expanded, JCR, Current Contents and Biological Abstracts

From early AIDS vaccine to HIV cure research with analytical treatment interruption trials: a study participant testimonial

Author List
William Freshwater

Abstract

In this article, I would like to discuss my experience as a participant in a recent analytical treatment interruption (ATI) study at the National Institutes of Health (NIH study 16-I-0118, an exploratory, open label study of vedolizumab in participants with HIV infection undergoing an analytical treatment interruption). This is the second HIV-related study that I have taken part in, the first one being an HIV/AIDS vaccine study with Remune back in the early 1990s.

Article Category

HIV cure research

Article Type

Viewpoints

Posted Date

22-10-2019

Tables & Figures

Back to top